Biofern Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 27.00 Cr
as on 06-10-2024
- Paid Up Capital ₹ 27.00 Cr
as on 06-10-2024
- Company Age 5 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 14.00 Cr
as on 06-10-2024
- Satisfied Charges ₹ 13.00 Cr
as on 06-10-2024
- Revenue %
(FY 2023)
- Profit 100.07%
(FY 2023)
- Net Worth 108.00%
(FY 2023)
- Total Assets 192.47%
(FY 2023)
About Biofern Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 27.00 Cr and a paid-up capital of Rs 27.00 Cr.
The company currently has active open charges totaling ₹14.00 Cr. The company has closed loans amounting to ₹13.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Biofern Life Sciences Private Limited India is Mh Prasad as COMPANY SECRETARY. Burugupalli Srinivas, Garikipati Kumar, and Kolathur Srinarayanan serve as directors at the Company.
- CIN/LLPIN
U24100KA2019PTC120330
- Company No.
120330
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Jan 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bengaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Biofern Life Sciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mh Prasad  | Company Secretary | 16-Aug-2022 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Burugupalli Srinivas | Director | 11-Jan-2019 | Current |
| Garikipati Kumar | Director | 11-Jan-2019 | Current |
| Kolathur Srinarayanan | Director | 11-Jan-2019 | Current |
Financial Performance of Biofern Life Sciences.
Biofern Life Sciences Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 100.07% increase in profit. The company's net worth Soared by an impressive increase of 108%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Biofern Life Sciences?
In 2023, Biofern Life Sciences had a promoter holding of 39.33% and a public holding of 60.67%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Andhra Medi Pharma India Private LimitedActive 15 years 27 daysBurugupalli Srinivas, Garikipati Kumar and 1 more are mutual person
- Andhra Mariscos Enterprises Private LimitedActive 7 years 3 days
Burugupalli Srinivas and Kolathur Srinarayanan are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 17 Nov 2023 | ₹14.00 Cr | Open |
Karnataka Bank Ltd. Creation Date: 24 Jul 2023 | ₹2.00 Cr | Satisfied |
Karnataka Bank Ltd. Creation Date: 18 Apr 2023 | ₹3.00 Cr | Satisfied |
How Many Employees Work at Biofern Life Sciences?
Unlock and access historical data on people associated with Biofern Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biofern Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biofern Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
